Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid

Lezot, F., Chesneau, J., Navet, B. et al. (9 more authors) (2015) Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid. BONE, 73. pp. 51-59. ISSN 8756-3282

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2014 Elsevier Inc. All rights reserved.
Keywords: Bone resorption; RANKL; Zoledronic acid; Skeleton growth; Side effect
Dates:
  • Published: April 2015
  • Published (online): 19 December 2014
  • Accepted: 13 December 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 28 Apr 2016 12:28
Last Modified: 28 Apr 2016 12:32
Published Version: http://dx.doi.org/10.1016/j.bone.2014.12.011
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.bone.2014.12.011
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics